Explore our site to find valuable resources, cutting-edge research, and breaking news on the gender equality dimensions of HIV/AIDS. You can contribute by uploading your own materials, networking with fellow colleagues, and locating an event near you.
In the News
Vaginal ring for HIV prevention effective and acceptable
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa heard last month. Some additional analyses suggested a higher level of effectiveness. Moreover, African women who took part in the study told researchers that they liked the product, found it easy to use and preferred it to possible alternatives such as tablets or vaginal gels. Read full article here.
Hail to Malawi's She-Chief Fighting HIV
When the International AIDS Conference is held in Africa, not only do you get Elton John, Queen Latifah and the rest of the celebrity set in attendance, but African royalty appear as well. They’re concerned for their people—and it’s these traditional leaders, as opposed to politicians, that often hold sway. That’s especially true in Malawi, where 10.3% of the population lives with HIV. Reflecting gender disparities in the country, more women (12.9 percent) than men (8.1 percent) have the disease, according to the UK-based organization, AVERTing HIV and AIDS. However, Malawi’s rate of new infection has been dropping, and perhaps that’s in part due to Senior Chief Theresa John Ndovie Kachindamoto. Read full article here.
HIV Infection Decreases Survival in Women With Invasive Cervical Cancer
HIV infection significantly decreases survival among women with invasive cervical cancer, according to a study conducted in Botswana. This was the case even though most women with HIV received antiretroviral therapy. “Cervical cancer is the most common cause of cancer death among African women, and the HIV epidemic intensifies this burden,” wrote study authors led by Scott Dryden-Peterson, MD, of Brigham and Women’s Hospital in Boston. The use of antiretroviral therapy for HIV can reduce the frequency and duration of the HPV strains that can cause cervical cancer, but incidence of the malignancy has not decreased since HIV treatment expanded. The impact of HIV on survival from cervical cancer has not been well studied before. Read full article here.